Table 4.
Characteristics | PedsQL (children’s score) | PedsQL (parents’ score) | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Generic mean (sd) | p-value | Cancer mean (sd) | p-value | Fatigue mean (sd) | p-value | Generic mean (sd) | p-value | Cancer mean (sd) | p-value | Fatigue mean (sd) | p-value | |
Gender distribution | ||||||||||||
Female | 68.8(11.0) | 0.73 | 69.6(12.1) | 0.17 | 77.1(14.2) | 0.98 | 55.5(16.6) | 0.09 | 68.6(12.2) | 0.58 | 72.8(22.4) | 0.57 |
Male | 66.0(13.3) | 70.4(11.2) | 75.5(13.8) | 66.9(16.4) | 66.6(14.2) | 77.9(17.7) | ||||||
Age groups | ||||||||||||
2 to 4 years | 69.6(21.7) | 67.9(13.6) | 77.3(26.5) | |||||||||
5 to 12 years | 70.9(11.3) | 0.13 | 66.8(12.2) | 0.34 | 77.9(14.4) | 0.68 | 58.1(15.4) | 0.52 | 66.9(13.6) | 0.99 | 78.6(19.1) | 0.40 |
13 to 18 years | 63.5(12.6) | 73.1(9.9) | 74.4(13.3) | 60.7(12.6) | 67.3(14.1) | 72.4(10.7) | ||||||
Diagnostic groups | ||||||||||||
Leukaemia | 68.4(12.3) | 0.63 | 73.2(8.7) | 0.11 | 77.0(13.5) | 0.36 | 63.8(16.8) | 0.68 | 69.3(13.9) | 0.37 | 77.1(18.9) | 0.08 |
Solid tumours | 66.7(15.3) | 70.6(7.7) | 79.1(15.1) | 63.1(22.6) | 62.3(9.3) | 83.1(7.0) | ||||||
CNS tumours | 59.8(1.5) | 50.5(17.7) | 63.2(6.2) | 54.7(10.4) | 63.7(16.6) | 54.6(16.1) | ||||||
Treatment modality | ||||||||||||
Chemotherapy | 70.4(12.4) | 0.09 | 73.8(8.3) | 0.01 | 80.7(11.4) | 0.01 | 65.8(17.1) | 0.04 | 69.0(13.1) | 0.12 | 79.2(18.5) | 0.02 |
Combined therapy | 58.7(7.8) | 59.6(12.7) | 63.2(11.3) | 47.4(4.2) | 59.3(12.4) | 59.7(15.7) |
Note: Scores range from 0 to 100; higher scores represent a better HRQOL. Statistics are tests for within group differences and significant differences are highlighted in bold type. sd standard deviation